🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicenter retrospective study evaluated consecutive patients with la...
Status
Completed
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2019-07-01
Trial ID
NCT06265883
Treatments Being Tested
Vast majority of patients with hepatocellular carcinoma (HCC) present with ...
Status
Unknown
Location
Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre
Start Date
2014-12
Trial ID
NCT02794337
This is a prospective, open-labelled study to evaluate the efficacy and saf...
Status
Unknown
Location
Multiple Locations
Start Date
2022-05-01
Trial ID
NCT05340231
Treatments Being Tested
This trial is a multi-center, phase III, randomized (1:1) clinical trial. T...
Status
Unknown
Location
The First Affiliated Hospital of Sun Yat-sen University
Start Date
2019-09-15
Trial ID
NCT04143191
Treatments Being Tested
Pain is the main complication after TACE(Transcatheter Arterial Chemoemboli...
Status
Unknown
Location
The Second Affiliated Hospital, Chongqing Medical University
Start Date
2023-01-05
Trial ID
NCT05670561
Treatments Being Tested
This trial is designed to be the initial prospective pilot investigation of...
Status
Active Not Recruiting
Location
Loyola University Medical Center
Start Date
2013-07
Trial ID
NCT01918683
Treatments Being Tested
This project will include at least 40 patients with hepatocellular carcinom...
Status
Completed
Location
Kaohsiung Medical University Hospital
Start Date
2007-02
Trial ID
NCT00834028
This is a multicenter, Phase I/II study in patients with non-resectable hep...
Status
Recruiting
Location
National Taiwan University Hospital
Start Date
2020-10-06
Trial ID
NCT03812874
Treatments Being Tested
Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies in...
Status
Unknown
Location
The Fourth Affiliated Hospital of Haerbin Medical University
Start Date
2009-08
Trial ID
NCT00960518
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2006-05
Trial ID
NCT00335829
Treatments Being Tested